Healthcare News and Research

Latest Healthcare News and Research

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, has entered into an exclusive license agreement with Norgine B.V., a European specialist pharmaceutical company, for the commercialization of MuGard in Australia and New Zealand.

27 Oct 2014

Practice Fusion releases new mobile-optimized EHR platform for medical professionals

Practice Fusion, the nation's largest cloud-based electronic health records (EHR) platform, today launched a new EHR for Practice Fusion's community of more than 112,000 medical professionals. Practice Fusion received more than 20,000 requests from users for a mobile-optimized EHR experience for the Apple iPad, iPad Mini and Android tablets.

27 Oct 2014

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.

27 Oct 2014

MinuteClinic enters into clinical collaboration agreement with Lifespan

MinuteClinic, the retail medical clinic of CVS Health, and Lifespan, Rhode Island's largest health system, which includes five partner hospitals and multiple physician groups, announced today that they have entered into a clinical collaboration agreement.

27 Oct 2014

Roper Industries' GAAP revenue increases 7% to $884 million in Q3 2014

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2014.

27 Oct 2014

EMA's CHMP adopts final opinion on ARIAD Pharmaceuticals' Iclusig (ponatinib)

ARIAD Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted its final opinion on Iclusig (ponatinib) following the recommendations made by the Pharmacovigilance Risk Assessment Committee earlier this month.

27 Oct 2014

Concord Medical gets approval to establish Datong Meizhong Jiahe Cancer Center

Concord Medical Services Holdings Limited, an operator of specialty cancer hospitals and the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has received relevant government approvals to establish a free-standing radiotherapy cancer center, Datong Meizhong Jiahe Cancer Center ("Datong Center") in Datong City, Shanxi Province.

27 Oct 2014

AHI develops TRUHEAL Wound Program for diabetics

After nine years of research and development, Advanced Health Institute, a medical startup company, has developed a process that is changing lives called the TRUHEAL Wound Program. Because of the high success rate, major insurers pay AHI based on results of treatments, a revolutionary approach to traditional healthcare.

27 Oct 2014

NAHQ sponsors National Healthcare Quality Week

National Healthcare Quality Week is sponsored by the National Association for Healthcare Quality. This annual national recognition event brings attention to the profession of healthcare quality and celebrates the work of the individual healthcare quality management professionals who work diligently to enhance the quality of care and optimize patient safety.

27 Oct 2014

Digoxin drug may be adaptable for ALS treatment, study suggests

Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS), a progressive, paralyzing disease, suggests new research at Washington University School of Medicine in St. Louis.

27 Oct 2014

CTI BioPharma acquires worldwide rights to tosedostat

CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.

27 Oct 2014

Study shows that obese children may mistake asthma symptoms, overuse rescue medications

New research shows obese children with asthma may mistake symptoms of breathlessness for loss of asthma control leading to high and unnecessary use of rescue medications. The study was published online in the Journal of Allergy and Clinical Immunology, the official scientific journal of the American Association of Allergy, Asthma and Immunology.

27 Oct 2014

Population Council to present research on novel approaches to HIV prevention at HIV R4P 2014

The Population Council will present new research on novel approaches to HIV, sexually transmitted infections (STIs), and unintended pregnancy prevention at the HIV Research for Prevention Conference, (HIV R4P) in Cape Town, South Africa. HIV R4P, which runs 28–31 October, is the first global scientific meeting dedicated exclusively to research on biomedical HIV prevention.

27 Oct 2014

Financial burden higher in patients treated for colorectal cancer

Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

27 Oct 2014

Economic impact of hypoglycaemia: an interview with Dr Klaus Henning Jensen

Hypoglycaemia is the term used to describe a lower than normal blood sugar level. There are a number of things that actually need to be formally defined in order for a hypoglycaemic episode to be diagnosed.

26 Oct 2014

UCSF report: California Tobacco Control Program under threat

California's position as a leader in tobacco control is under threat, according to a new report from the UC San Francisco Center for Tobacco Control Research and Education. Once a highly successful program and international model, the state's anti-tobacco efforts now appear to be waning due to the decreased spending power of the California Tobacco Control Program, a resurgence of the tobacco industry in state politics, and the emergence of new unregulated tobacco products.

26 Oct 2014

Monash University research explores long-term costs for two main causes of stroke

New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on.

26 Oct 2014

University of Derby wins award for collaborative social media campaign

The University of Derby has won an award at the inaugural East Midlands Innovation in Healthcare awards, for a collaborative social media campaign with Leicestershire Partnership NHS Trust and ADHD Solutions.

From University of Derby Online Learning 25 Oct 2014

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Vancive Medical Technologies and Aspen Medical Europe Ltd. today announced an agreement for the exclusive distribution of the Vancive BeneHold Absorbent Wound Dressing portfolio in the United Kingdom and Ireland.

25 Oct 2014

Study finds lower mortality at hospitals that treat high volume of SAH cases

For patients with a severe type of stroke called subarachnoid hemorrhage (SAH), treatment at a hospital that treats a high volume of SAH cases is associated with a lower risk of death, reports a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

25 Oct 2014